Effects of sodium ferulate on rats sith severe acute pancreafitis
Gong Ping,Zhang Yu,Song Zheng-Jun
DOI: https://doi.org/10.3760/cnia.j.issn.1671-0282.2009.05.015
2009-01-01
Abstract:Objective To study the therapeutic effects and mechanism of Sodiwn Ferulate( SF) on rats with severe acute pancreatitis( SAP) induced by L-arginine. Method A total of 60 adult SD rats were randomly and equally divided into control group, SAP group and SF group, with 20 rats in each group. The rat model of SAP was established by injecting 2.5 g/kg Larginine at a dose of intraperitonea]ly twice at an interval of 1 hour, and rats in SAP group and SF groups were administrated intraperitoneally with 20% L-arginine solution(2. 5 g/kg x 2) twice at an interval of 1 hour; rats in control group were injected intraperitoneafly with the same volume of physiological saline twice alone. At 5 minutes after L-arginine administration, rats in SF group were injected with SF solution (100 mg/kg, qd x 3 d) via the tail vein, and rats in the other two groups received a sham injection of the same volume of physiological saline alone. The characteristics of ascites, the pathological changes of pancreatic tissue and the serum levels of amylase( AMY), endothelin- 1 (Er- 1), tumor necrosis factor-a( TNF-a), interleukin-6( IL. 6) and the contents of malonaldehyde (MDA), superoxide dismutase (SOD), reduced glutathione (GSH) of pancreatic tissue of rats and prognosis were compared at 72 hours after L-arginine administration. Measurement data were evaluated by one-way ANOVA, and numeration data were assessed by Fisher's exact test. P <0.05 was considered statistically significant. Results Compared with control group, at 72 hours after L-arginine administration, rats in SAP group presented characteristically histopathological changes of SAP with significantly higher serum levels of AMY, Ef-i, TNF-a, IL-6 and MDA of pancreatic tissue[ (9715.5 ± 301.3) IU/L vs. (729.2 ± 134.2 IU/L;(25.32±3.67) ng/Lvs. (14.32±2.69) ng/L;(102.95± 11.24) ng/Lvs. (38.62±3.87) ng/L; (538.63 ±9.53) ng/L vs. (186.35 ± 1.19) ng/L; (34.8 ± 3.9) mol/kg vs. (8.1 ± 2.1) mol/kg, all P < 0.01], andlowerGSHandSODinthepancreatictissue[(7.l±0.6)mg/kgvs. (16.9±l.9)mg/kg;(6423± 1978 ) kU/kg vs. (29905 ± 2945) kU/kg,hoth P< 0.01]. Compared with SAP model group,at 72 hours after administration of nine,the pathological lesions of SAP in rats of SF group were significantly alleviated with lower pathological scores (P < 0.05), lower serum levels of AMY, Fr-i, TNF-a, IL-6 and MDA in the pancreatic tissue [(8104.6 ±149.9) IU/Lvs. (9715.5 ±301.3) IU/L;(20.26±5.86) ng/Lvs.(25.32±3.67) ng/L; (84.19±15.14) ng/Lvs. (102.95±11.24) ng/L;(458±5.37) mol/kgvs. (538.63±9.53) ng/L;(28.3± 2.5) mol/kg vs. (34.8 ±3.9) moVkg,afl P <0.05], and higher SOD and GSH in the pancreatic tissue[(8.5 ±1.4) mg/kgvs. (7.1±0.6) mg/kg;(i0316±28i0) kU/kgvs. (6423±1978) kU/kg, bothP<0.05].At 72 hours the death rate in SF group was lower than that in SAP group, but the difference had no significance (P = 0.25). Conclusiotis SF can scavenge oxygen-derived free radicals, upgrade the contents of SOD and GSH of pancreatic tissue, decrease the levels of serum proinflammatory cytokines and Fr- 1 , ameliorate the pathological lesions of pancreatic tissue in rats, and has the capability of decreasing death rate, so it possesses a distinct advantage for the treatment of SAP.